LBF20207PG42: Difference between revisions
No edit summary |
No edit summary |
||
Line 8: | Line 8: | ||
|SysName=9-oxo-11a,15R-dihydroxy-prosta-5Z,13E-dien-1-oic acid | |SysName=9-oxo-11a,15R-dihydroxy-prosta-5Z,13E-dien-1-oic acid | ||
|Common Name=&&15 (R) -Prostaglandin E_2&&9-oxo-11a,15R-dihydroxy-prosta-5Z,13E-dien-1-oic acid&& | |Common Name=&&15 (R) -Prostaglandin E_2&&9-oxo-11a,15R-dihydroxy-prosta-5Z,13E-dien-1-oic acid&& | ||
|Source= | |||
|Chemical Synthesis= | |||
|Metabolism= | |||
}} | }} | ||
{{Lipid/Footer}} | {{Lipid/Footer}} |
Revision as of 22:00, 24 November 2009
LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
IDs and Links | |
---|---|
LipidBank | XPR1779 |
LipidMaps | - |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF20207PG42 |
15 (R) -Prostaglandin E2 | |
---|---|
Structural Information | |
9-oxo-11a,15R-dihydroxy-prosta-5Z,13E-dien-1-oic acid | |
| |
Formula | C20H32O5 |
Exact Mass | 352.224974134 |
Average Mass | 352.46508 |
SMILES | C(CC[C@@H](O)C=C[C@H]([C@H]1CC=CCCCC(O)=O)[C@@H](CC1=O)O)CC |
Physicochemical Information | |
Spectral Information | |
Mass Spectra | |
UV Spectra | |
IR Spectra | |
NMR Spectra | |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
|